<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Europese Commissie keurt ALUNBRIG® (brigatinib) goed voor ALK+ Non-Small Cell Lung Cancer bij patiënten die eerder behandeld zijn met Crizotinib, Advancing Treatment Paradigm in Europa	</title>
	<atom:link href="https://www.novumpr.nl/2018/11/27/europese-commissie-keurt-alunbrig-brigatinib-goed-voor-alk-non-small-cell-lung-cancer-bij-patienten-die-eerder-behandeld-zijn-met-crizotinib-advancing-treatment-paradigm-in-europa/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/11/27/europese-commissie-keurt-alunbrig-brigatinib-goed-voor-alk-non-small-cell-lung-cancer-bij-patienten-die-eerder-behandeld-zijn-met-crizotinib-advancing-treatment-paradigm-in-europa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=europese-commissie-keurt-alunbrig-brigatinib-goed-voor-alk-non-small-cell-lung-cancer-bij-patienten-die-eerder-behandeld-zijn-met-crizotinib-advancing-treatment-paradigm-in-europa</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Tue, 27 Nov 2018 14:43:47 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
